Hemmo Pharma LLP
About Hemmo Pharma LLP
Data last updated:
Hemmo Pharma LLP is a limited liability partnership (LLP) based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 March 2016 and has been in existence for over 10 years.
The LLP is registered with the Registrar of Companies (ROC), Mumbai, under LLPIN AAF-9673. Its GSTIN is 27AAJFH2928P1ZS (Maharashtra).
The LLP has a total obligation of contribution of ₹15.5 Lakh. It is led by designated partners including Rekha Jairam Hemrajani and Madhu Vikram Utamsingh.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
The LLP is associated with 1 brand: Hemmo Pharmaceuticals. Court records list 3 cases involving the LLP, including 3 filed by the LLP; 1 case is pending.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressOffice No. 2608 26th Floor Prestige Tower Wing C, Shakti Mills Lane Off Dr. E. Moses Road Mahalaxmi, Mumbai, Maharashtra, India – 400011
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Hemmo Pharma LLP FY 2025 filings available
Financial Statement Summary of Hemmo Pharma LLP
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Income | •••• | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• | •••• |
| Profit After Tax | •••• | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• | •••• |
| Assets and Liabilities | |||||
| Partners' Contribution | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Hemmo Pharma LLP
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Hemmo Pharma are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Designated Partners of Hemmo Pharma LLP
Hemmo Pharma has 3 current designated partners and 4 former designated partners. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rekha Jairam Hemrajani | Designated Partner | 03 Jul 2017 | 9 Years 3 Months | Current |
| Madhu Vikram Utamsingh Also directs: Shyro Health Private Limited | Designated Partner | 17 Mar 2016 | 10 Years 6 Months | Current |
| Vikram Utamsingh Also directs: Shyro Health Private Limited | Designated Partner | 17 Mar 2016 | 10 Years 6 Months | Current |
Charges & Borrowings of Hemmo Pharma LLP
Hemmo Pharma LLP does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Hemmo Pharma LLP
Hemmo Pharma LLP has 3 court cases on record: 3 filed by Hemmo Pharma. 1 case is pending and 2 are disposed. Status as checked between 01 Oct 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 3 | 0 | 1 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Interim or miscellaneous application | Filed by the company against an individual | Pending |
| Bombay High Court | Court case (SJ) | Filed by the company against an individual | Disposed |
| Bombay High Court | Court case (COMSS) | Filed by the company against an individual | Disposed |
Full case history
All 3 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Hemmo Pharma LLP
Hemmo Pharma operates one associated brand: Hemmo Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Synthetic peptides are manufactured for research, clinical, and commercial applications. | hemmopharma.com |
Employees and EPFO Compliance at Hemmo Pharma LLP
Employment history and EPFO contributions of people linked to Hemmo Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Hemmo Pharma LLP
Hemmo Pharma LLP has 8 designated partner changes on record since 2016: 5 appointments and 3 cessations. The latest: Lalita Anil Matta was appointed as Partner on 11 Jan 2024.
Credit Ratings, Litigation & Regulatory Alerts for Hemmo Pharma LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Hemmo Pharma LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Hemmo Pharma LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Hemmo Pharma LLP
Hemmo Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAJFH2928P1ZS | Maharashtra | Active | 01 Nov 2021 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Hemmo Pharma LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hemmo Pharma LLP
Hemmo Pharma is an active limited liability partnership based in Mumbai, Maharashtra, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 17 March 2016 (10+ years old) and is registered under LLPIN AAF-9673.
Hemmo Pharma has 3 current designated partners:
- Rekha Jairam Hemrajani - Designated Partner
- Madhu Vikram Utamsingh - Designated Partner
- Vikram Utamsingh - Designated Partner
The GSTIN of Hemmo Pharma is 27AAJFH2928P1ZS, registered in Maharashtra.
The LLPIN (Limited Liability Partnership Identification Number) of Hemmo Pharma is AAF-9673. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Hemmo Pharma has 3 court cases on record: 3 filed by the LLP. 1 is pending.
Hemmo Pharma was incorporated on 17 March 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
Lalita Anil Matta was appointed as Partner on 11 Jan 2024. Lalita Anil Matta ceased to be Designated Partner on 10 Jan 2024. Rekha Jairam Hemrajani ceased to be Partner on 10 Nov 2022. Hemmo Pharma has 8 designated partner changes on record in total.
The registered office of Hemmo Pharma is at Office No. 2608 26th Floor Prestige Tower Wing C, Shakti Mills Lane Off Dr. E. Moses Road Mahalaxmi, Mumbai, Maharashtra, India – 400011.
The total obligation of contribution is ₹15.5 Lakh.
Hemmo Pharma operates in the pharma industry, in the drug formulation and development segment.